chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Small repository at his injection site like a small nodule after receiving this injection; He did not feel sick, but felt like he was drifting, had malaise, and body aches; He did not feel sick, but felt like he was drifting, had malaise, and body aches; Felt like he was in a fog for 2 days; This spontaneous case was reported by a pharmacist and describes the occurrence of INJECTION SITE NODULE (Small repository at his injection site like a small nodule after receiving this injection), MALAISE (He did not feel sick, but felt like he was drifting, had malaise, and body aches), PAIN (He did not feel sick, but felt like he was drifting, had malaise, and body aches) and BRAIN FOG (Felt like he was in a fog for 2 days) in an elderly male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Influenza day before (day before/ He had received an influenza vaccine on 21SEP2023.) on 21-Sep-2023, Pfizer Biontech (He has had 5 prior covid shots from Pfizer. He never experienced any symptoms following the Pfizer COVID-19 vaccines.), Pfizer Biontech (He has had 5 prior covid shots from Pfizer. He never experienced any symptoms following the Pfizer COVID-19 vaccines.), Pfizer Biontech (He has had 5 prior covid shots from Pfizer. He never experienced any symptoms following the Pfizer COVID-19 vaccines.), Pfizer Biontech (He has had 5 prior covid shots from Pfizer. He never experienced any symptoms following the Pfizer COVID-19 vaccines.) and Pfizer Biontech (He has had 5 prior covid shots from Pfizer. He never experienced any symptoms following the Pfizer COVID-19 vaccines.). Past adverse reactions to the above products included No adverse event with Influenza day before, Pfizer Biontech, Pfizer Biontech, Pfizer Biontech, Pfizer Biontech and Pfizer Biontech.    On 22-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE NODULE (Small repository at his injection site like a small nodule after receiving this injection), MALAISE (He did not feel sick, but felt like he was drifting, had malaise, and body aches), PAIN (He did not feel sick, but felt like he was drifting, had malaise, and body aches) and BRAIN FOG (Felt like he was in a fog for 2 days). At the time of the report, INJECTION SITE NODULE (Small repository at his injection site like a small nodule after receiving this injection) outcome was unknown and MALAISE (He did not feel sick, but felt like he was drifting, had malaise, and body aches), PAIN (He did not feel sick, but felt like he was drifting, had malaise, and body aches) and BRAIN FOG (Felt like he was in a fog for 2 days) had resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   He did not felt sick, but felt like he was drifting, had malaise, and body aches. Concomitant medications were not reported.  No treatment information was provided by the reporter.
Patient reports she did not have any pain the day of vaccination but the next day her shoulder and collar bone were very sore. She thought this was strange because it's usually my arm that is sore (second booster dose). Her injection pain has been getting worse to the point that it wakes  her up in the middle of the night. It is extremely sensitive to the touch (feels like she have a gigantic bruise) and has a burning sensation.
Previous history: I have given birth to three healthy children and had zero miscarriages/ pregnancy complications.  At my first dose of the covered vaccine, I had just begun my second trimester of pregnancy, I was 13 weeks pregnant. 2 weeks later, at a routine doctor's appointment, it was found that the baby had no heartbeat (The baby had died). The report showed that the baby had stopped growing 1 to 3 days after the vaccine was given.
Morning of 2/5/2021, pt experienced swelling, redness, and itching on right arm
This patient received Hepatitis B vaccine on 10/16/00. The mother called today to report of pus oozing from the site on the left arm, beginning 10/21-10/22/00 weekend. Denies pain at site but does have redness / swelling. Nothing used on the site except alcohol . Denies fever 11/27/00 several attempts to follow up more has not responded.
Information has been received from a registered nurse via a company representative concerning a female patient of unknown age with no drug reactions or allergies. The patient's concomitant medication and pertinent medical history were not reported. On an unknown date the patient was vaccinated with the first dose of GARDASIL 9 (dose, unit, route, lot # and exp. date not reported) and she didn't have any reaction. On an unknown date, the patient received her second dose of GARDASIL 9 (dose, unit, route, lot # and exp. date not reported) and developed a rash on her arm. Her rash was described as red and raised at the injection site to elbow. No lab diagnostics studies were performed. The patient did not seek medical attention, she called to nurse in her mother's office and sent picture of rash. The patient was treated with BENADRYL. Her redness had gotten better, but still had the bumps. Action taken with GARDASIL 9 was not applicable (also reported as therapy was not discontinued). The causal relationship between the event and GARDASIL 9 was not reported. Additional information is not expected we have no consent to contact the physician.
Swelling, pain, blue - bruise around area of injection site on day of injection. Everything cleared out after about 2 weeks. Patient did not do anything to treat the area.
Patient had been complaining of worsening LE edema 3 days prior to event. She was seen at the clinic and given medication for it. Patient apparently developed high BP at home ( worsening HTN ?) and passed away at home 5 days after vaccination (05/11). No further info.
inconsolable crying for 5hr p/vax; no fever;refused to nurse;no tx;
sick with flu like symptoms; Sneezing; coughing; muscle pain; feeling tired; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Sep2021 at 15:45 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 13Sep2021, the patient got sick with flu like symptoms and the symptoms included sneezing, coughing, muscle pain and was feeling tired. These were common symptoms of a flu, but the fact was that the patient was sick like that only once before in 2016 after she travelled by plain to abroad.  The patient got sick like she got like virus vaccine, which she did not appreciate at all. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sick with flu like symptoms, sneezing, coughing, muscle pain, feeling tired, common symptoms of a flu was resolving at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
nausea, vertigo, stabbing pain in arm approx 30min p/vax; felt OK next day;
Initial unsolicited report received from other health care professional via other company (Pfizer) on 1 February 2016. Manufacturer number: 2016043485. This case involves a patient (age and gender was not reported) who was vaccinated with a dose of Flu Vaccine (batch number, expiration date, dose, dose in series, route and site of administration were not reported) on an unspecified date. Medical history included egg allergy. Concomitant medications were not reported. On an unspecified date, following the vaccination, the patient experienced loses consciousness and stops breathing. Lab data and corrective treatments were not reported. Outcome of events was not reported. Upon internal review company decided to consider event serious because of important medical events loss of consciousness and stops breathing. List of documents held by sender: none. Sender's Comments: The manufacturer of the INFLUENZA VACCINE involved in this report is not known. Loss of consciousness and apnea following administration of INFLUENZA VACCINE has been reported. This case is not sufficiently documented. More information including patient's medical history, concomitant medications are needed to further assess this case. Based on the information provided; the role of vaccine cannot be assessed.
On 6/8 while sitting in my chair, all of the sudden I developed a really uncomfortable pain right in the middle of my chest, my fingers and toes began to tingle. I sat and breathed deep for a few moments and it passed. Later that evening about 2:30pm while walking the pain returned and it was a constant hurting pain followed by SOB which lasted about 10 minutes.  I felt extremely exhausted the remainder of the day. 6/10 the pressure in my chest returned but no pain was associated and the tingling sensation in both my hands and feet returned also, so I drove to the ER where various test were performed. No heart attack was visible but they could not figure out where the pain was coming from so I have appointment scheduled on 6/28 with my PCP to see if we can figure this thing out
This case was reported by a healthcare professional and described the occurrence of injection site bleeding in a subject of unspecified age and gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On 27 July 2011 the subject received unspecified dose of ENGERIX B (1 ml, unknown route). On 27 July 2011, less than one day after vaccination with ENGERIX B, the subject experienced injection site bleeding. On 28 July 2011, the event was resolved. The healthcare professional considered the event was probably related to vaccination with ENGERIX B. The healthcare professional reported 3 incidences of subjects experiencing bleeding at the injection site with ENGERIX B. This is case 2 of 3 (see case IDs A0939441A and A0939444A for details of the other reports). Follow-up information received on 22 September 2011 indicated that no further information was available for this adverse event.
one of two pts who devel local react consisting of 8x6 cm erythema, induration and edema w/ pain after injection
2 days after receiving vaccine, had muscle pain left arm and leg. No tingling sensation. 1st 2-3 days mild sensation. Last 5 days, feet "really hurt". No muscle weakness, just tingling sensations and some pain. Bothers her more at night.
Patient had Tdap approximately 7am. 5 Minutes after she experienced tightness of her neck; warm feeling; started to cough; had SOB took prednisone; Zyrtec; Combivent inhaler brought to E.R. Admitted overnight.  05/17/2007 MR received for an o/n admission for c/o lip swelling following her DPT vax. She was treated for an allergic reaction and the pt. developed PVCs and acute vertigo.  Pt was unable to walk after that due to vertigo and was admitted. Pt. reports fatigue and "room spinning"  PE: Somnolent.  Horizontal nystagmus to the right.  Ataxic gait. DX: Anaphylaxis.  Acute on Chronic Vertigo
myelitis onset approx 1wk p/vax;cont paresthesia lower extremities, hands, weakness of lower extremities;tx w/IV steroids DEC97 & JUN98;to start Betainter-feron for poss MS JUN98;
Fever; joint pain; body aches; throwing up; headache; This is a spontaneous report from a contactable consumer, the patient. This 51-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EC3246),  dose  1, single dose via an unspecified route of administration in the left arm on 22Jan2021 at 14:30 (at the age of 51 years-old) for COVID-19 vaccination. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive  any other vaccine within 4 weeks prior to the vaccine. Concomitant medications included zolpidem (AMBIEN) and lisinopril. On 22Jan2021 at 16:45, the patient experienced fever, joint pain, body aches, throwing up and headache. The events resulted in a physician's office visit. Treatment was not received for the events. The clinical outcome of fever, joint pain, body aches, throwing up and headache was not recovered. It was also reported that since the vaccination, the patient was tested for COVID-19 on 27Jan2021: polymerase chain reaction (PCR) nasal swab and was negative.
Severe pain in right shoulder and in underarm (near or in lymph nodes).  Fatigue (almost immediately), aches and joint pain (almost immediately), and low fever (about 36 hours later).
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age. The patient was vaccinated with 3 doses of GARDASIL (lot # not reported) at the same time, via a single injection on 09-AUG-2012. No other co-suspects were reported. No concomitant medications were reported. No adverse effect reported. It was unknown if the patient had sought medical attention. Additional information has been requested.
Fever and seizure, happened the night after vaccination was given. Brought to ER where he received TYLENOL supp.
Cellulitis; Swelling at injection site; Redness at injection site; This case was reported by a other health professional via call center representative and described the occurrence of injection site cellulitis in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number PP9L5, expiry date 16th October 2021) for prophylaxis.   On 14th May 2020, the patient received Kinrix (intramuscular) .5 ml. On 14th May 2020, 6 hrs after receiving Kinrix, the patient experienced injection site cellulitis, injection site swelling and injection site erythema. The patient was treated with cephalexin (Keflex). On an unknown date, the outcome of the injection site cellulitis, injection site swelling and injection site erythema were recovered/resolved.   It was unknown if the reporter considered the injection site cellulitis, injection site swelling and injection site erythema to be related to Kinrix.  Additional information was received as follows: About 6 hours after Kinrix vaccination, the patient experienced swelling and redness at the injection site.  The Patient went to the emergency room the following day.  The patient was diagnosed with Cellulitis and was put on 10 days course of Keflex. At the time of report, the patient was now completely recovered. The reporter consented for follow up. This is 1 of 3 cases reported.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020091764:Same reporter US-GLAXOSMITHKLINE-US2020091771:Same reporter
Pt received Hep B #2 dose on 06/08/09. She had a little redness at the site and went to bed. She woke in the middle of the night with neck pain. The pain has progressively gotten worse. She stated that her neck is not stiff and she has full range of motion. I advised her to seek medical attention from her MD. Also gave her phone number to the Health Center. Will follow up with her tomorrow.
Client began to have itching on face and neck, rash appeared, Benadryl 50mg and stayed in office for 1 hour for monitoring, client left with spouse. Contacted client next day and clients symptoms had improved.
Service Member presented to the clinic Nov 10. He states the day after receiving Anthrax experienced some left facial paresthesia that lasted a couple of hours. States symptoms resolved on their own, denied any further symptoms or recurrence.
Felt weak, thirsty, must have been running fever. Drank a lot of liquids and crawled in bed; too weak to take temperature. Also had breathing problems, heart racing, headache. Did not take any medication. Was OK by next day.
Patient received a sub-optimal COVID-19 vaccine due to a storage and handling error. Vaccine was stored in a regular freezer prior to being refrigerated and them administered. Requested that a VAERS form be submitted for this patient.
No adverse events. The vaccine was administered in an error to the patient who is 16 year old.
sick; Ached all over; felt really bad; This is a spontaneous report from a contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 13Jan2021 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that three and a half days later (Jan2021) she got really sick. The patient ached all over on Jan2021, and for two days felt really bad on Jan2021. She did not seem to have the typical COVID symptoms. She got tested for COVID and did not have it. Over the next few days she gradually felt better, and then 10 days later she felt fine. She was due to have the second shot this Wednesday (03Feb2021). She was unsure if she should take it or not. The outcome of the events was recovered on Jan2021.   Information on the lot/batch number has been requested.
patient previously received the Pfizer COVID vaccine, and is now taking Paxlovid (COVID treatment); patient previously received the Pfizer COVID vaccine, and is now taking Paxlovid (COVID treatment); This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Mar2022 at 12:15 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 56 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Elbow replacement" (unspecified if ongoing); "traumatic arthritis" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "recovered" (07May2022) and all described as "patient previously received the Pfizer COVID vaccine, and is now taking Paxlovid (COVID treatment)". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: Recovered quickly with neg retest. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever (101); Body aches; Fatigue; Lethargy; Headache; Minor shortness of breathe; This is a spontaneous report received from a contactable consumer (patient) via COVAES. This 56-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0161) via an unspecified route of administration in the left arm on 21Apr2021 at 12:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included back injury and arthritis, both from unknown dates and unknown if ongoing. The patient had no known allergies and was not diagnosed with COVID-19 prior to vaccination. The patient had no concomitant medications. The patient previously received the first dose of BNT162B2 (lot number EP7533) on 31Mar2021 at 12:15 (at the age of 56-years-old) for COVID-19 immunisation. On 22Apr2021 at 06:00 the patient experienced fever reported as 101, body aches, fatigue, lethargy, headache and minor shortness of breath. The events were reported as non-serious and did not require hospitalization. No treatment was received for the events. The clinical outcomes of fever reported as 101, body aches, fatigue, lethargy, headache and minor shortness of breath were recovered in Apr2021. It was also reported that since vaccination the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Showed erythema localized to a lesion erythema localized to area of injection in (L) thigh 3in x 1.5in no induration, warm to palpation erythema localized to area of injection (R) thigh 0.8cm x 0.1 cm no induration. Warm to palpation. Discussed reaction to vaccination. Okay to use ice to alleviate pain intermittently. The red may continue to spread. Discussed S&Sx of infection. Will monitor. Fam understands possibility of knot forming or spreading of erythema. Continue w/antipyretics as needed.
Associate became itchy on chest and arms. Throat tightening. Blood pressure 168/120. Given 125mg Benedryl. Taken to ED for further evaluation.
I took the pneumococcal 13 injection. I have fever, chills, extremely weak, cold sweats, bad a injection site swelling, joint pain.
Pt received vaccine 12/13/2005, on 12/14/2005 presented with nausea, vomiting, headache, dizziness, body aches, eyes burning.
I had a breakthrough case. I was vaccinated on 03/31/2022 then on 06/18/2022 I started having symptoms of a scratchy throat, stuffy nose and a fever. On 06/19/2022 I got a really high fever. I did a home COVID-19 test and it came back positive so I called my Dr.'s office and they prescribed me PAXLOVID. I felt fever, stuffy nose symptoms for a few days. I never recovered from the scratchy throat.
Soreness in the arm; This is Spontaneous report from a contactable other healthcare professional (patient). A 71-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1284), via an unspecified route of administration on 30Dec2020 at single dose for COVID-19 immunization. Medical history included blood pressure (ongoing), cholesterol (ongoing) and heart issues. Ongoing concomitant medication included losartan for blood pressure, rosuvastatin calcium (CRESTOR) for cholesterol. The patient experienced soreness in the arm, nothing spectacular on an unspecified date. The patient is a dentist, dental surgeon.  For the soreness that was, just for an hour and two. There was no other consequences whatsoever. The patient did a COVID test a little over week ago in Jan2021, it came negative. The patient had no treatment for the event. The outcome of the event was unknown.
left shoulder with 4cmx4cm erythema and 4cmx2cm hardness underneath- warm and firm to touch; no erythematous streaks or pain to touch
Red, swollen area on left deltoid.  Itchy/tight area where vaccine was administered.
Local injection site reactions consisting of erythema; Local injection site reactions consisting of induration; Local injection site reactions consisting of significant pruritus; This spontaneous case was received on 09-Sep-2023 from a healthcare professional (physician) (reference number SEQW23-02126) and concerned a 64-year-old, female patient.   The patient's medical history and concomitant medications were not reported. As reported, the patient had received annual flu vaccination over the past 20-30 years without any adverse events.   On 06-Sep-2023, the patient was vaccinated with  Flucelvax Quadrivalent (influenza vaccine inact sag 4v; anatomical location: arm, dose, route of administration, and indication: not reported). The batch number was not reported.  On the same date, after receiving the Flucelvax Quadrivalent, the patient experienced local injection site reactions consisting of erythema, induration, and significant pruritus.   At the time of the initial reporting, the patient had not recovered from the events of 'vaccination site erythema', 'vaccination site induration', and 'vaccination site pruritus'.   The reporter did not provide a causality assessment.  The case was assessed as non-serious.  This case is linked to case 202303956 due to the same reporter.